Creatine for Women: What the Evidence Actually Shows

The most common question we get about creatine is some version of but is it safe for women? The honest answer is: for healthy, non-pregnant adult women, the available evidence is reassuring — and the evidence base is much larger than most people realise. The 2021 Smith-Ryan lifespan review pooled creatine trials in women from adolescence through post-menopause, and the 2020 de Guingand meta-analysis aggregated safety outcomes across 951 non-pregnant women (from the 29 studies that tracked adverse events, out of 656 creatine studies the review's search identified in total; the review explicitly excluded pregnancy from its population). Both reached conclusions in line with the larger general-population literature since the 1990s: in the populations studied, 3-5 g/day of plain creatine monohydrate was well tolerated and, alongside training, effective Smith-Ryan 2021.

The lingering hesitation is mostly cultural. Creatine got branded in the 1990s as a meat-head supplement, and the marketing skewed male. The trial literature did not. Women were included in the seminal 1996 Hultman saturation study, the 1997 Vandenberghe long-term performance trial, and most subsequent RCTs. The female-specific reviews summarising those data are now strong enough to draw reasonably confident conclusions for healthy adult women.

Educational journalism, not medical advice. Every claim here is checked against its cited sources by editor Timothy Bunce — a health writer, not a physician. It isn’t specific to your situation: for health decisions, talk to your own clinician. How we work →

Some links in this article are affiliate links. If you buy through one, The Beachside Reader earns a commission at no extra cost to you. It never changes which products we pick, or what we say about them. Full affiliate disclosure →

Same dose, same protocol

The studied protocol is the same for women: trials have used 3-5 g/day of plain creatine monohydrate, taken daily. Researchers haven't identified a reason for sex-specific dosing, and creatine handling — absorption, distribution, muscle saturation — appears broadly similar in men and women once body size and baseline muscle creatine are accounted for. Whether creatine suits you, and how much, is a question your clinician or pharmacist can help with.

Women may have lower baseline muscle creatine stores than men, partly because dietary creatine comes mostly from meat and fish and women average lower red-meat intake. A lower starting point may leave more room to respond to supplementation. Smith-Ryan's 2021 review suggested that, in some metrics, the proportional response to creatine may actually be greater in women than in men Smith-Ryan 2021.

Strength and lean-mass evidence

Smith-Ryan's 2021 lifespan review summarised creatine RCTs in women across resistance-training programs and found gains in lean mass and strength comparable to those reported in male-only trials Smith-Ryan 2021. The 2015 Lanhers meta-analysis, which pooled 60 trials, found small-to-moderate but statistically significant lower-limb strength gains versus training alone (effect sizes of roughly 0.34 for squat, 0.30 for leg press, and 0.24 for lower-limb strength overall) — gains the authors reported as independent of population characteristics, training protocols, and creatine dosing or duration Lanhers 2015.

The mechanism is the same as in men: more phosphocreatine in the muscle means more ATP availability during short, hard efforts. That allows a slightly heavier set, a couple more reps, a faster sprint — small per-session edges that compound over months.

The caveat: creatine without resistance training does very little for body composition. The lean-mass gains in the trials come from creatine plus lifting, not creatine alone. If you're not training the muscles you want to grow, the supplement is largely an expensive way to hold a bit of extra intramuscular water.

The hair-thinning myth

The single most cited fear is a 2009 South African rugby-player study reporting that 25 g/day of creatine for seven days followed by 5 g/day for 14 days raised serum dihydrotestosterone (DHT) by roughly 50% from baseline. DHT is the androgen most implicated in androgenetic alopecia — pattern hair loss — which is where the worry originates.

That study has aged badly. It has never been replicated. It used a loading dose roughly five times the standard daily dose. It measured DHT, not hair shedding or follicle behaviour. The DHT elevation was within normal clinical range. And subsequent reviews — the 2021 Antonio paper, the 2020 de Guingand safety meta — have searched the trial literature and found no signal of hair loss as a reported outcome across hundreds of trials and thousands of participants Antonio 2021 de Guingand 2020.

Could a woman with strong genetic predisposition to androgenetic alopecia experience subtle effects? The evidence is too thin to say no with confidence. But there is no signal of women losing hair in the trials we have. If you're concerned about hair loss, particularly with a family history, it's a reasonable question to raise with your doctor.

Menstrual cycle, contraceptives, hormones

The 2020 de Guingand meta-analysis tracked adverse outcomes — gastrointestinal symptoms, kidney and liver markers, and body weight — across 951 women in 29 studies, and found no signal of harm on any of those measures at standard 3-5 g/day doses. None of the 29 included studies specifically monitored menstrual cycle, hormonal, or reproductive outcomes, so the review itself is silent on cycle length, flow, ovulation, fertility, contraceptive interaction, or estradiol/progesterone/testosterone profiles — those outcomes simply weren't tracked, which is not the same as having been checked and found clean de Guingand 2020.

Smith-Ryan's 2021 review did highlight one interesting cycle-related finding: creatine may attenuate the strength dip some women experience in the late luteal phase, possibly because the cellular hydration and ATP buffering helps blunt the effects of progesterone-driven catabolic shifts. The finding comes from a small number of studies and the proposed mechanism hasn't been confirmed, so treat it as a promising lead rather than an established effect.

Perimenopause and post-menopause

This is where the female-specific case gets strongest. Estrogen decline at menopause accelerates loss of lean mass and bone mineral density. The 2017 Chilibeck meta-analysis pooled 22 creatine-plus-resistance-training trials (721 participants, mixed-sex, mean age 57-70) in older adults and found significantly greater gains in lean tissue mass and in chest-press and leg-press strength compared with resistance training alone — though the analysis did not assess bone density and reported its results for the pooled group as a whole, not broken out by sex Chilibeck 2017.

The 2019 Candow review on sarcopenia made a similar point: creatine may modestly enhance the muscle gains older adults get from resistance training, while effects on bone are less certain. The supplement alone won't carry the weight — the lifting does most of the work — and older adults, who are more likely to have kidney problems or take regular medications, should check with their clinician or pharmacist first.

Pregnancy and post-partum

The evidence here is preliminary but interesting. Creatine does cross the placenta. Pre-clinical animal studies and small human pilots have suggested maternal creatine supplementation may protect the fetal brain against birth-asphyxia injury, and Australian research groups are actively running larger trials.

That said, we are not yet at the point where blanket recommendations are warranted. The trials are not large enough to rule out unknown effects, and the responsible default is to discuss any supplement with your obstetrician. Most maternal-health guidelines remain conservative. The 2020 de Guingand safety meta-analysis, cited throughout this piece, explicitly excluded pregnant women from its 951-woman dataset — its safety conclusions cover non-pregnant females from menarche through post-menopause, not pregnancy itself — so the reassurance above rests on the smaller pre-clinical and pilot studies described here, not on that review de Guingand 2020.

Mood, sleep, and cognition

The cognitive evidence is the youngest and fastest-growing branch of the creatine literature. Avgerinos's 2018 meta-analysis found creatine may improve short-term memory and reasoning in healthy people, though the effects varied across small studies Avgerinos 2018; groups with lower baseline creatine, such as vegetarians, have been proposed as likely responders. The 2022 Forbes review summarised an expanding but early body of work exploring whether creatine may have antidepressant and neuroprotective effects, largely in small trials that added creatine to standard treatment Forbes 2022. That research is preliminary: depression and other mood disorders need care from a clinician, and creatine is not a substitute for treatment or a reason to change medication.

Some of the cognitive studies used higher doses than the 3-5 g/day muscle studies, and the safety and efficacy data at those doses are thinner. Higher-dose use is something to discuss with a clinician, not something to try on your own.

Practical takeaways

• Studied dose: Trials in women have used 3-5 g/day of plain creatine monohydrate; whether it's right for you, and how much, is a question for your clinician or pharmacist.
• Loading: Some studies used a short, higher-dose loading phase to raise muscle stores faster; lower daily amounts reach similar levels over a few weeks without the higher intake.
• Form: Monohydrate. The fancy variants (HCl, ethyl ester, buffered) charge a premium for chemistry that has never out-performed monohydrate in head-to-head trials.
• Combine with: Resistance training. The muscle evidence comes overwhelmingly from trials that combine the supplement with lifting.
• Less of a worry than you've heard: Hair (no signal in the trials) and water retention (early weight gain is mostly fluid held in muscle, not bloat). Menstrual effects haven't been specifically studied, so mention any changes to your doctor.
• Talk to your doctor or pharmacist first if: You're pregnant, breastfeeding, under 18, have kidney or liver disease, or take regular medications.

Related: the full creatine evidence walk-through; strength training through menopause.

References